BARCLAYS PLC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 138 filers reported holding ANI PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$541
+31.6%
9,321
+22.0%
0.00%
Q2 2023$411
+45.2%
7,639
+7.0%
0.00%
Q1 2023$283
+7.2%
7,141
+9.1%
0.00%
Q4 2022$264
-99.8%
6,546
+50.4%
0.00%
Q3 2022$140,000
-35.8%
4,353
-40.8%
0.00%
Q2 2022$218,000
-34.1%
7,352
-37.8%
0.00%
Q1 2022$331,000
-77.5%
11,812
-63.0%
0.00%
Q4 2021$1,472,000
+477.3%
31,932
+310.6%
0.00%
Q3 2021$255,000
+37.8%
7,776
+48.1%
0.00%
Q2 2021$185,000
-69.2%
5,251
-68.4%
0.00%
Q1 2021$601,000
+34.5%
16,616
+8.0%
0.00%
Q4 2020$447,000
-3.2%
15,386
-6.1%
0.00%
Q3 2020$462,000
+6.7%
16,381
+22.3%
0.00%
Q2 2020$433,000
-14.9%
13,393
+7.3%
0.00%
Q1 2020$509,000
-40.3%
12,477
-9.7%
0.00%
Q4 2019$852,000
+27.4%
13,813
+50.4%
0.00%
Q3 2019$669,000
-34.6%
9,187
-26.3%
0.00%
-100.0%
Q2 2019$1,023,000
-39.9%
12,462
-48.3%
0.00%0.0%
Q1 2019$1,701,000
+30.8%
24,115
-16.5%
0.00%0.0%
Q4 2018$1,300,000
+7.2%
28,883
+34.7%
0.00%0.0%
Q3 2018$1,213,000
+72.1%
21,449
+103.0%
0.00%0.0%
Q2 2018$705,000
-32.9%
10,568
-41.5%
0.00%0.0%
Q1 2018$1,051,000
+44.8%
18,060
+60.2%
0.00%0.0%
Q4 2017$726,000
+98.4%
11,275
+62.0%
0.00%
Q3 2017$366,000
+33.1%
6,960
+18.3%
0.00%
Q2 2017$275,000
-36.0%
5,882
-32.4%
0.00%
Q1 2017$430,000
-31.6%
8,697
-16.1%
0.00%
-100.0%
Q4 2016$629,000
+184.6%
10,367
+210.8%
0.00%
Q3 2016$221,000
-81.4%
3,336
-84.3%
0.00%
-100.0%
Q2 2016$1,187,000
+214.0%
21,267
+86.3%
0.00%
+100.0%
Q1 2016$378,000
-67.8%
11,415
-56.2%
0.00%0.0%
Q4 2015$1,173,000
+83.6%
26,069
+59.3%
0.00%0.0%
Q3 2015$639,000
-21.4%
16,362
+24.6%
0.00%0.0%
Q2 2015$813,000
-88.7%
13,127
-88.7%
0.00%
-87.5%
Q1 2015$7,220,000
+13784.6%
116,438
+12353.3%
0.01%
Q4 2014$52,000
-54.8%
935
-77.3%
0.00%
Q3 2014$115,000
+538.9%
4,116
+679.5%
0.00%
Q2 2014$18,000
-58.1%
528
-61.7%
0.00%
Q1 2014$43,000
+7.5%
1,377
-29.6%
0.00%
Q4 2013$40,000
+122.2%
1,957
-0.8%
0.00%
Q3 2013$18,0001,9730.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 272,801$15,838,8267.50%
Global Alpha Capital Management Ltd. 525,528$30,512,1563.06%
Rubric Capital Management LP 847,011$49,177,4591.84%
Ranger Investment Management 426,848$24,782,7951.64%
Parkman Healthcare Partners LLC 111,802$6,491,2241.19%
MARATHON CAPITAL MANAGEMENT 71,670$4,161,1601.05%
Mesirow Financial Investment Management, Inc. 3,862$224,2280.98%
Deep Track Capital, LP 400,000$23,224,0000.90%
1492 Capital Management LLC 18,178$1,055,4150.68%
Phocas Financial Corp. 75,213$4,367,0000.64%
View complete list of ANI PHARMACEUTICALS INC shareholders